Wei Li

机构：Shanghai Cancer Institute, Shanghai Pulmonary Hospital, Shenzhen Pingle Orthopedic Hospital · ORCID：0000-0001-7960-0372

发表论文 62 篇 · 总被引 970 次 · h-index 15

代表论文

• Taletrectinib in ROS1 + Non–Small Cell Lung Cancer: TRUST (2025 · Journal of Clinical Oncology · 被引 55)
• Evaluation of ultrasound-guided lateral thoracolumbar interfascial plane block for postoperative analgesia in lumbar spine fusion surgery: a prospective, randomized, and controlled clinical trial (2019 · PeerJ · 被引 49)
• Design of DOX-GNRs-PNIPAM@PEG-PLA Micelle With Temperature and Light Dual-Function for Potent Melanoma Therapy (2021 · Frontiers in Chemistry · 被引 24)
• Efficacy and safety of KN046, a novel bispecific antibody against PD-L1 and CTLA-4, in patients with non-small cell lung cancer who failed platinum-based chemotherapy: a phase II study (2023 · European Journal of Cancer · 被引 23)
• Dual integrin αvβ 3 and NRP-1-Targeting Paramagnetic Liposome for Tumor Early Detection in Magnetic Resonance Imaging (2018 · Nanoscale Research Letters · 被引 22)
• Mitral Geometry on the Mechanism of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy (2024 · Journal of the American Society of Echocardiography · 被引 20)